Tularemia 2026 Co-Chairs: Amy Rasley, PhD Deputy Group Leader, Microbiology/ Immunology, Lawrence Livermore National Laboratory, Livermore, USA and Nick Fischer, PhD, Staff Scientist, Lawrence Livermore National Laboratory, Livermore, USA

Scientific Organizing Committee

  • Joel Bozue, USAMRIID, USA, email
  • Roberto De Pascalis, Center for Biologics Evaluation and Research, FDA, USA, email
  • Nick Fischer, Lawrence Livermore National Laboratory, USA email (Co-Chair)
  • Carl Gelhaus, Appili Therapeutics, USA, email
  • Thomas Henry, INSERM, Lyon, France, email
  • Joseph Horzempa, West Liberty University, USA email 
  • Jason Huntley, Texas A&M College of Medicine USA, email
  • Tom Kawula, Washington State University, USA, email
  • Girish Kirimanjeswara, The Pennsylvania State University, USA, email
  • Karl Klose, University of Texas-San Antonio, USA, email
  • Max Maurin, University of Grenoble Alpes, France, email
  • Matt Meinig, USAMRIID, USA, email
  • Jeannine Petersen, Centers for Disease Control, USA, email
  • Amy Rasley, Lawrence Livermore National Laboratory, USA email (Co-Chair)
  • Lydia Roberts, Rocky Mountain Laboratories, NIAID, NIH; USA, email
  • Marina Šantić, University of Rijeka, Croatia, email
  • Anders Sjostedt, University of Umea, Sweden, email
  • Jiri Stulik, University of Defence, Czech Republic, email
  • Monique L van Hoek, George Mason University email